Plasma Amyloid-β, Total Tau, and Neurofilament Light Chain Across the Alzheimer’s Disease Clinical Spectrum: A Population-Based Study

BACKGROUND: Plasma biomarkers have emerged as a promising approach for characterizing pathophysiology in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). OBJECTIVE: We aimed to characterize plasma biomarkers for AD and neurodegeneration across the AD clinical continuum, and to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yi, Hou, Tingting, Li, Yuanjing, Liu, Rui, Cong, Lin, Liu, Keke, Liu, Cuicui, Han, Xiaolei, Ren, Yifei, Tang, Shi, Winblad, Bengt, Blennow, Kaj, Wang, Yongxiang, Du, Yifeng, Qiu, Chengxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657676/
https://www.ncbi.nlm.nih.gov/pubmed/37899059
http://dx.doi.org/10.3233/JAD-230932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657676/
https://www.ncbi.nlm.nih.gov/pubmed/37899059
http://dx.doi.org/10.3233/JAD-230932

Ejemplares similares